Skip to main content
. 2020 May 14;14:93. doi: 10.3389/fncel.2020.00093

TABLE 2.

Demographics and illness details for human post-mortem hippocampal samples from patients with Alzheimer’s disease and controls.

Case ID Diagnostic Gender Age (years) PMI (h) Medication
1557 Control M 86 7 NA
1679 Control F 90 13 NA
1694 Control M 58 5 NA
1752 Control F 88 24 NA
1818 Control M 78 5 NA
1870 Control F 97 7 NA
1888 Control F 93 5 NA
1949 Control M 86 7 NA
1127 Alzheimer’s, no psychosis M 82 8 NA
1785 Alzheimer’s (early onset), no psychosis F 74 4 NA
1800 Alzheimer’s, no psychosis M 84 5 NA
1803 Alzheimer’s (cortico-basal dementia), no psychosis M 72 18 NA
1822 Alzheimer’s, no psychosis F 82 6 NA
1824 Alzheimer’s, no psychosis F 84 6 NA
1829 Alzheimer’s, no psychosis M 83 5 NA
1847 Alzheimer’s, no psychosis F 75 16 NA
1879 Alzheimer’s (early onset), no psychosis F 63 10 NA
1882 Alzheimer’s (early onset), no psychosis M 72 5 NA
1037 Alzheimer’s (early onset) with psychosis M 56 16 NA
1273 Alzheimer’s (early onset) with psychosis M 61 8 NA
1321 Alzheimer’s (early onset) with psychosis M 63 8 NA
1380 Alzheimer’s with psychosis F 85 10 NA
1386 Alzheimer’s with psychosis M 81 3 NA
1443 Alzheimer’s (early onset) with psychosis F 63 6 NA
1444 Alzheimer’s (early onset) with psychosis M 62 20 NA
1457 Alzheimer’s with psychosis F 76 13 NA
1614 Alzheimer’s with psychosis F 85 12 NA
1736 Alzheimer’s with psychosis F 86 8 NA

PMI, Post-mortem interval; M, Male; F, Female; NA, Not applicable.